Primary progressive multiple sclerosis: Cerebrospinal fluid considerations

Multiple Sclerosis

Volumn 10, Issue SUPPL. 1, 2004, Pages

  Freedman, Mark S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cerebrospinal fluid or CSF; Intrathecal immunoglobulin; Multiple sclerosis; Oligoclonal bonding; Primary progressive MS

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G;

ARTICLE; BLOOD BRAIN BARRIER; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; IMMUNOBLOTTING; IMMUNOELECTROPHORESIS; LABORATORY DIAGNOSIS; MEMBRANE PERMEABILITY; MULTIPLE SCLEROSIS; NEUROIMAGING; POLYACRYLAMIDE GEL ELECTROPHORESIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 3042546836     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1028oa     Document Type: Article

References (10)

1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
2. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831-35.
3. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
4. Schumacher GA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122: 552-68.
5. Reiber H, Otto M, Trendelenburg C, Wormek A. Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin Chem Lab Med 2001; 39: 324-32.
6. Rijcken CA, Thompson EJ, Teelken AW. An improved, ultra-sensitive method for the detection of IgM oligoclonal bands in cerebrospinal fluid. J Immunol Methods 1997; 203: 167-69.
7. Felgenhauer K. Barrier concepts and CSF analysis. J Neurol 1992; 239: 59-60.
8. Bashir K, Whitaker JN. Current immunotherapy for demyelinating diseases. Arch Neurol 2002; 59: 726-31.
9. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 27-30.
10. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 1990; 113: 1269-89.